These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 183614)

  • 1. Actions and interactions of theophylline and imidazole on cardiac contractility, phosphorylase activation and cyclic AMP.
    Verma SC; McNeill JH
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):4-8. PubMed ID: 183614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glucagon on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    Brunt ME; McNeill JH
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):42-52. PubMed ID: 210728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate.
    McNeill JH; Verma SC
    J Pharmacol Exp Ther; 1974 Jan; 188(1):180-8. PubMed ID: 4148934
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):597-600. PubMed ID: 209506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of tolbutamide on contractility and cyclic adenosine 3':5'-monophosphate concentration in the intact beating rat heart.
    Brown JD; Brown ME
    J Pharmacol Exp Ther; 1977 Jan; 200(1):166-73. PubMed ID: 189007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):735-43. PubMed ID: 193168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade by burimamide of the effects of clonidine on cardiac contractility phosphorylase activation and cyclic adenosine monophosphate in isolated guinea pig heart.
    Verma SC; McNeill JH
    Indian J Physiol Pharmacol; 1980; 24(2):77-83. PubMed ID: 6247271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and inotropic effects of verapamil in perfused rat heart.
    Hess ME; Shanfeld J; Levine NR
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():81-8. PubMed ID: 174169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H2-histaminergic activity of clonidine in the guinea pig heart.
    Verma SC; McNeill JH
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):95-106. PubMed ID: 195988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcium oncardiac phosphorylase activation, contractile force and cyclic AMP in euthyroid and hyperthyroid rat hearts.
    Hartley EJ; McNeill JH
    Can J Physiol Pharmacol; 1976 Aug; 54(4):590-5. PubMed ID: 184894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326).
    Hayes JS; Bowling N; Pollock GD; Robertson DW
    J Pharmacol Exp Ther; 1986 Apr; 237(1):18-24. PubMed ID: 3007737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylephrine effects on cardiac contractility adenyl cyclase, and phosphorylase.
    McNeill JH; Davis RS; Muschek LD
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):317-27. PubMed ID: 4337939
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force.
    Keely SL
    Mol Pharmacol; 1979 Mar; 15(2):235-45. PubMed ID: 89626
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociations between changes in myocardial cyclic adenosine monophosphate and contractility.
    Henry PD; Dobson JG; Sobel BE
    Circ Res; 1975 Mar; 36(3):392-400. PubMed ID: 163151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclic nucleotide levels and glycogen phosphorylase activity by acetylcholine and epinephrine in perfused rat hearts.
    Gardner RM; Allen DO
    J Pharmacol Exp Ther; 1976 Aug; 198(2):412-9. PubMed ID: 181558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle.
    Dobson JG; Ross J; Mayer SE
    Circ Res; 1976 Sep; 39(3):388-95. PubMed ID: 182412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.